Risk and Benefits of Electronic Cigarettes to Older Smokers at High Risk for Lung Cancer

NCT05144542 · clinicaltrials.gov ↗

NA

Phase

ACTIVE_NOT_RECRUITING

Status

140

Enrollment

OTHER

Sponsor class

Conditions

Lung Carcinoma

Interventions

PROCEDURE: Participants will vape electronic cigarettes for 26 weeks.
DRUG: Nicotine Replacement
DRUG: Nicotine Replacement

Sponsor

M.D. Anderson Cancer Center

Collaborators

[object Object]